MTCM
ARRY

Mint Tower Capital Management’s Array Biopharma Inc ARRY Stock Holding History

Mint Tower Capital Management’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-20,000
Closed -$927K – 285
2019
Q2 		$927K Buy
+20,000
New +$562K 0.1% 162

Other funds holding ARRY

ASN
Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Mint Tower Capital Management's ARRY Position: Q3 2019 in Review

Mint Tower Capital Management sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 20,000 shares — an estimated $927K sold.

Mint Tower Capital Management first reported a position in ARRY in Q2 2019 and held it in 1 quarter. The position peaked at $927K in Q2 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

  • Mint Tower Capital Management reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
  • Mint Tower Capital Management sold 20,000 Array Biopharma Inc shares in Q3 2019, an estimated $927K.
  • Mint Tower Capital Management first reported a position in Array Biopharma Inc in Q2 2019 and held it in 1 quarter.
  • Mint Tower Capital Management's Array Biopharma Inc position peaked at $927K in Q2 2019.
  • 1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on Mint Tower Capital Management's 13F filing for Q3 2019, filed 14 Nov 2019.